Almirall (LBTSF) Stock Price, News & Analysis
Company Description
Almirall (OTC Link: LBTSF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.9B.
LBTSF has gained 70.4% over the past year. Shares last traded at $15.35.
This page collects what Stock Titan holds for LBTSF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Almirall (LBTSF) stock last closed at $15.35. Over the past 12 months, the stock has gained 70.4%. At a market capitalization of $2.9B, LBTSF is classified as a mid-cap stock with approximately 214.6M shares outstanding.
Latest News
Almirall has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include management, earnings. View all LBTSF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Almirall (LBTSF) currently stands at 158.1 thousand shares, up 9.1% from the previous reporting period, representing 0.2% of the float. Since July 2025, short interest has increased by 84.7%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Almirall (LBTSF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 44.3 to 1000.0 days.
LBTSF Company Profile & Sector Positioning
Almirall (LBTSF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing LBTSF often look at related companies in the same sector, including Procaps Group Sa (PROCF), Almirall SA (ALMRY), Hypera Sa (HYPMY), Hikma Pharmaceuticals Plc (HKMPY), and Hikma Pharma (HKMPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LBTSF's relative position within its industry.